Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Argan (AGX) EBITDA (2016 - 2026)

Argan (AGX) has disclosed EBITDA for 17 consecutive years, with $50.1 million as the latest value for Q1 2026.

  • Quarterly EBITDA rose 64.23% to $50.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $145.1 million through Jan 2026, up 75.88% year-over-year, with the annual reading at $145.1 million for FY2026, 75.88% up from the prior year.
  • EBITDA hit $50.1 million in Q1 2026 for Argan, up from $32.2 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $50.1 million in Q1 2026 to a low of $1.6 million in Q1 2022.
  • Historically, EBITDA has averaged $17.3 million across 5 years, with a median of $13.1 million in 2024.
  • Biggest five-year swings in EBITDA: plummeted 84.63% in 2022 and later soared 905.02% in 2023.
  • Year by year, EBITDA stood at $7.1 million in 2022, then crashed by 41.54% to $4.2 million in 2023, then skyrocketed by 535.23% to $26.4 million in 2024, then rose by 21.99% to $32.2 million in 2025, then soared by 55.72% to $50.1 million in 2026.
  • Business Quant data shows EBITDA for AGX at $50.1 million in Q1 2026, $32.2 million in Q4 2025, and $33.9 million in Q3 2025.